Spherix (SPEX)
Spherix News
Spherix Announces First Quarter 2012 Financial Results
GlobeNewswire about 17 days agoBETHESDA, Md. -- Spherix Incorporated -- an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and provider of technical and regulatory consulting services to food, ...
SPHERIX INC Files SEC form 10-Q, Quarterly Report
about 17 days agoSPHERIX INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Trans
about 37 days agoNew Studies Conducted By Spherix Support Use Of D-Tagatose To Reduce And Stabilize Atherosclerotic Plaques
Benzinga about 44 days agoSpherix Inc. Earnings Conference Call & Business Update scheduled for 1:00 pm ET today
about 51 days agoReminder: Spherix to Hold Business Update Conference Call April 11 at 1:00 p.m. Eastern Time
PR Newswire about 52 days agoBETHESDA, Md., April 10, 2012 /PRNewswire/ -- Spherix Incorporated (NASDAQ: SPEX - News) – an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and providers of technical ...
SPHERIX INC Financials
about 57 days agoSPHERIX INC Files SEC form 10-K, Annual Report
about 64 days agoSpherix Announces 2011 Financial Results
PR Newswire about 65 days agoBETHESDA, Md., March 28, 2012 /PRNewswire/ -- Spherix Incorporated (NASDAQ: SPEX - News) – an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and provider of technical ...
SPHERIX INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
about 70 days agoSPHERIX INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
about 78 days agoSPHERIX INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
about 80 days agoSpherix to Present Newest Work on Lipoproteins and Atheromas at Pittcon, the World's Largest Annual Expo for Laboratory Science
PR Newswire about 85 days agoBETHESDA, Md., March 8, 2012 /PRNewswire/ -- Spherix Incorporated (NASDAQ: SPEX - News) – an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and providers of technical ...
You may also be interested in these SPEX related companies
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| SPEX | 0.75 | -0.03 | -3.85% | 3.12M |
| SPCHB | 1.716 | +0.03 | +1.54% | 3.054M |
| SPCHA | 1.22 | -0.15 | -10.95% | 15.14M |
| SPBC | 12.85 | +0.00 | +0.00% | 22.23M |
| SPB | 33.10 | -1.42 | -4.11% | 1.787B |
| SPAR | 4.21 | -0.29 | -6.44% | 151.29M |
| SPAN | 17.51 | +0.01 | +0.06% | 51.10M |
| SPAB | 1.07 | +0.04 | +3.88% | |
| YGE | 2.71 | +0.11 | +4.23% | 378.53M |
| YELP | 15.58 | -1.13 | -6.76% |
